Astrana Health Inc.
ASTH | NASDAQ
$33.79
+$0.24 (+0.72%)
Sep 22, 2026, 9:37 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 3.84B | 3.53B | 3.18B | 2.9B | 2.42B | 2.25B | 2.03B | 1.72B | 1.59B | 1.45B | 1.39B | 1.33B | 1.3B | 1.22B | 1.14B | 1.05B | 955.17M | 861.11M | 597.86M | 402.76M | 175.64M |
Cost of Revenue | 3.49B | 3.2B | 2.87B | 2.6B | 2.13B | 1.98B | 1.76B | 1.48B | 1.35B | 1.22B | 1.17B | 1.11B | 1.08B | 1.01B | 944.69M | 863.41M | 770.11M | 676.26M | 455.53M | 283.69M | 136.21M |
Gross Profit | 354.53M | 328.47M | 309.54M | 293.91M | 285.81M | 273.86M | 271.39M | 247.35M | 246.66M | 235.97M | 214.96M | 217.07M | 220.5M | 204.8M | 199.48M | 181.65M | 185.06M | 184.86M | 142.33M | 119.07M | 39.42M |
Operating Income | 100.46M | 86.47M | 78.53M | 60.85M | 70.07M | 79.79M | 89.35M | 84.76M | 95.42M | 92.38M | 84.62M | 101.07M | 112.07M | 100.43M | 104.26M | 93.93M | 97M | 102.61M | 76.4M | 74.15M | 20.99M |
Interest Income | 17.23M | 13.66M | 12.16M | 11.39M | 11.65M | 12.82M | 14.51M | 15.88M | 15.38M | 15.2M | 14.21M | 10.9M | 7.85M | 4.94M | 1.98M | 930K | 1.13M | 1.27M | 1.22M | 983K | 563K |
Pretax Income | 60.1M | 49.71M | 39.61M | 30.21M | 51.35M | 66.42M | 80.82M | 83.64M | 94.84M | 94.43M | 89.84M | 99.37M | 102.62M | 87.76M | 86.62M | 53.73M | 6.96M | 74.78M | 56.52M | 78.95M | 84.45M |
Net Income | 40.55M | 30.23M | 22.49M | 9.54M | 25.26M | 35.01M | 43.15M | 62.46M | 68.42M | 62.42M | 60.72M | 45.76M | 46.89M | 45.67M | 46.3M | 62.67M | 73.76M | 74.47M | 60.71M | 46.94M | 12.66M |
Selling & General & Admin | 238.52M | 235.1M | 217.26M | 249.37M | 174.06M | 159.29M | 154.11M | 150.43M | 142.03M | 130.14M | 112.6M | 99.09M | 91.07M | 86.91M | 77.67M | 69.83M | 70.25M | 64.56M | 52.61M | 36.01M | 14.2M |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | 15.55M | 6.9M | 13.75M | -16.31M | 41.68M | 34.78M | 27.93M | 12.17M | 9.21M | 13.46M | 17.75M | 16.91M | 17.36M | 17.46M | 17.54M | 17.89M | 17.81M | 17.69M | 13.32M | 8.91M | 4.24M |
Operating Expenses | 254.07M | 242M | 231.01M | 233.06M | 215.74M | 194.06M | 182.04M | 162.59M | 151.24M | 143.59M | 130.34M | 116M | 108.43M | 104.37M | 95.21M | 87.72M | 88.06M | 82.25M | 65.93M | 44.92M | 18.44M |
Interest Expense | 67.34M | 58.72M | 49.93M | 40.48M | 31.62M | 32.82M | 33.1M | 30.45M | 25.37M | 20.42M | 16.1M | 13.25M | 11.9M | 10.12M | 7.92M | 6.4M | 4.95M | 4.94M | 3.87M | 2.82M | 1.85M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 3.74B | 3.44B | 3.1B | 2.84B | 2.35B | 2.17B | 1.95B | 1.64B | 1.5B | 1.36B | 1.3B | 1.23B | 1.18B | 1.12B | 1.04B | 951.12M | 858.17M | 758.51M | 521.46M | 328.61M | 154.65M |
Income Tax Expense | 20.87M | 18.73M | 15.53M | 20.47M | 23.71M | 27.13M | 30.89M | 26.02M | 28.23M | 32.21M | 31.99M | 40.96M | 48.28M | 39.62M | 39.52M | 26.42M | 8.93M | 28.5M | 21.68M | 24.8M | 24.92M |
Shares Outstanding (Basic) | 49.12M | 48.85M | 49.23M | 49.19M | 49.19M | 48.47M | 47.93M | 47.69M | 47.62M | 47.85M | 47.52M | 46.55M | 46.48M | 46.56M | 46.58M | 44.95M | 44.86M | 44.68M | 44.42M | 44.3M | 44.17M |
Shares Outstanding (Diluted) | 49.78M | 49.05M | 49.53M | 49.47M | 49.47M | 48.85M | 47.93M | 48.22M | 47.98M | 47.85M | 47.52M | 46.92M | 46.78M | 46.95M | 46.58M | 46.15M | 46.02M | 45.99M | 45.9M | 46.27M | 45.83M |
EPS (Basic) | 0.83 | 0.62 | 0.46 | 0.20 | 0.53 | 0.74 | 0.91 | 1.31 | 1.44 | 1.32 | 1.29 | 0.97 | 1.08 | 1.05 | 1.09 | 1.46 | 1.65 | 1.69 | 1.37 | 1.06 | 0.29 |
EPS (Diluted) | 0.82 | 0.61 | 0.46 | 0.20 | 0.52 | 0.73 | 0.90 | 1.30 | 1.44 | 1.32 | 1.29 | 0.97 | 1.06 | 1.03 | 1.06 | 1.42 | 1.60 | 1.63 | 1.32 | 1.02 | 0.28 |
EBITDA | 174.91M | 162.81M | 135.28M | 108.16M | 112.1M | 128.92M | 141.84M | 138.79M | 141.96M | 133.4M | 123.69M | 129.53M | 131.87M | 115.33M | 112.08M | 78.02M | 29.72M | 97.42M | 73.71M | 90.67M | 90.54M |
EBIT | 127.43M | 108.43M | 89.53M | 70.68M | 82.96M | 99.24M | 113.92M | 114.09M | 120.21M | 114.85M | 105.94M | 112.62M | 114.51M | 97.87M | 94.54M | 60.13M | 11.91M | 79.73M | 60.39M | 81.77M | 86.3M |
Depreciation & Amortization | 47.48M | 54.38M | 45.75M | 37.47M | 29.14M | 29.68M | 27.93M | 24.7M | 21.74M | 18.55M | 17.75M | 16.91M | 17.36M | 17.46M | 17.54M | 17.89M | 17.81M | 17.69M | 13.32M | 8.91M | 4.24M |
Add to Watchlist
Select watchlists to add or remove ASTH